Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8251 USD | -0.59% | -26.33% | -26.33% |
05-15 | Top Midday Decliners | MT |
05-15 | Bolt Biotherapeutics Stops Development of Trastuzumab Imbotolimod, Cuts Workforce by 50% | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.33% | 31.46M | |
+8.29% | 114B | |
+10.21% | 104B | |
+0.70% | 22.28B | |
-11.90% | 22.41B | |
-5.48% | 19.07B | |
-37.36% | 18B | |
-5.17% | 17.89B | |
+7.70% | 14.28B | |
+37.65% | 12.55B |
- Stock Market
- Equities
- BOLT Stock
- News Bolt Biotherapeutics, Inc.
- Bolt Biotherapeutics : SVB Leerink Raises Bolt Biotherapeutics' Price Target to $35 From $34, Maintains Outperform Rating